Fiona Du has over 25 years of senior management experience in innovative drug R&D, project evaluation, business development, and investment in biopharmaceutical industry in China. Her previous professional experiences include Chief Business Officer at Kangpu Biotech and CD Biopharma; Partner at Hongfeng Investment; Director at R&D Center of SIMM Chinese Academy of Sciences; Director at HUYA Bioscience, and co-founder of Crimson Biopharma.

Fiona holds a Ph.D. in medical genetics from Tokyo Women's Medical University, post-doc from University of Glasgow, UK,  and MD from Dongnan University School of Medicine.